|
Part 2: Current Treatments and Rising Phase 3 Disease-Modifying Therapies |
|
Enduring |
|
$0.00 |
|
Individualizing Narcolepsy: Using Clinical Evidence and Patient Factors to Improve Diagnosis and Optimize Therapeutic Management |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
|
Enduring |
|
$0.00 |
|
The Path of Least Resistance: New Agents and Emerging Strategies for Managing Childhood-Onset and Refractory Epilepsies (Credit Expired) |
|
Enduring |
|
$0.00 |
|
Part 2: Importance and Implications of Biomarkers in Diagnosis and Modern Treatment of Alzheimer’s Disease |
|
Enduring |
|
$0.00 |
|
Part 3: Diagnostic and Therapeutic Monitoring Strategies and their Potential Role in the Future of Disease-Modifying Therapy for Alzheimer’s Disease |
|
Enduring |
|
$0.00 |
|
When the Default is Not Enough: An Emergency Medicine Clinician's Guide to Novel Amyloid-Related Imaging Abnormalities in Alzheimer's... |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 AAPA Category I CME
- 1.00 Attendance
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward